Specifically, a better understanding of TDP-43 localization regulators will surely shed light on novel therapeutics that have the potential to be more effective earlier in disease, more generalizable to most ALS cases, and more informative biomarkers for diagnosis and analysis of progression for ALS. Here, TARDBP is linked to amyotrophic lateral sclerosis.